New agents and techniques for imaging prostate cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19690043.
- Also identified by DOI 10.2967/jnumed.109.061838 and PMC identifier 3336101.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The successful management of prostate cancer requires early detection, appropriate risk assessment, and optimum treatment. An unmet goal of prostate cancer imaging is to differentiate indolent from aggressive tumors, as treatment may vary for different grades of the disease. Different modalities have been tested to diagnose, stage, and monitor prostate cancer during therapy. This review briefly describes the key clinical issues in prostate cancer imaging and therapy and summarizes the various new imaging modalities and agents in use and on the horizon.
Medical subject headings
- Image Enhancement
- Molecular Probe Techniques
- Nuclear Medicine
- Prostatic Neoplasms
- Radioisotopes
- Tomography, Emission-Computed